Moderna CEO Stéphane Bancel testified before Congress Wednesday on raising the price of the experimental COVID-19 shot.
However, the conversation didn’t stay on the cost of the mRNA gene therapy.
Senator Rand Paul (R-KY) pressed Bancel on the increased risk of myocarditis from the shot.
“Is there a higher incidence of myocarditis among adolescent males age 16 to 24 after taking your vaccine?” Paul asked.
“The data have shown actually…there’s less myocarditis for people who get the vaccine versus who gets COVID infection,” Bancel responded.
“That is not true!” Paul emphasized.
“I’d like to enter into the record six peer-reviewed papers…that say the complete opposite of what you say.”
“I also spoke with your president just last week and he readily acknowledged in private, that yes, there is an increased risk of myocarditis. The fact that you can’t say it…
